81 FR 66030 - Agency Forms Undergoing Paperwork Reduction Act Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 81, Issue 186 (September 26, 2016)
Centers for Disease Control and Prevention
Federal Register Volume 81, Issue 186 (September 26, 2016)
| Page Range | 66030-66031 | |
| FR Document | 2016-23072 |
[Federal Register Volume 81, Number 186 (Monday, September 26, 2016)] [Notices] [Pages 66030-66031] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-23072] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day-16-0457] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639-7570 or send an email to [email protected]. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written [[Page 66031]] comments should be received within 30 days of this notice. Proposed Project Aggregate Reports for Tuberculosis Program Evaluation (OMB Control Number 0920-0457)--Reinstatement Without Change of a Previously Approved Collection--National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC, NCHHSTP, Division of Tuberculosis Elimination (DTBE) proposes a reinstatement without change of the Aggregate Reports for Tuberculosis Program Evaluation, previously approved under OMB Control Number 0920-0457. This request is for a three-year clearance. There are no revisions to the report forms, data definitions, or reporting instructions. DTBE is the lead agency for tuberculosis elimination in the United States. To ensure the elimination of tuberculosis in the United States, CDC monitors indicators for key program activities, such as finding tuberculosis infections in recent contacts of cases and in other persons likely to be infected and providing therapy for latent tuberculosis infection. In 2000, CDC implemented two program evaluation reports for annual submission: Aggregate report of follow-up for contacts of tuberculosis, and Aggregate report of screening and preventive therapy for tuberculosis infection (OMB No. 0920-0457). The respondents for these reports were the 68 state and local tuberculosis control programs receiving federal cooperative agreement funding through DTBE. This group will also respond to this collection of information. These Aggregate reports emphasize treatment outcomes, high-priority target populations vulnerable to tuberculosis, and programmed electronic report entry, which transitioned to the National Tuberculosis Indicators Project (NTIP), a secure web-based system for program evaluation data, in 2010. No other federal agency collects this type of national tuberculosis data, and the Aggregate report of follow- up for contacts of tuberculosis, and Aggregate report of screening and preventive therapy for tuberculosis infection are the only data source about latent tuberculosis infection for monitoring national progress toward tuberculosis elimination with these activities. CDC provides ongoing assistance in the preparation and utilization of these reports at the local and state levels of public health jurisdiction. CDC also provides respondents with technical support for NTIP access (Electronic--100%, Use of Electronic Signatures). The annual burden to respondents is estimated to be 226 hours. Estimated Annualized Burden Hours ---------------------------------------------------------------------------------------------------------------- Average Number of Number of burden per Type of respondent Form name respondents responses per response respondent (in hours) ---------------------------------------------------------------------------------------------------------------- Data clerks and Program Managers Follow-up and Treatment of 100 1 30/60 (electronic). Contacts to Tuberculosis Cases Form. Program Managers (manual)............... Follow-up and Treatment of 18 1 30/60 Contacts to Tuberculosis Cases Form. Data clerks (manual).................... Follow-up and Treatment of 18 1 3 Contacts to Tuberculosis Cases Form. Data clerks and Program Managers Targeted Testing and 100 1 30/60 (electronic). Treatment for Latent Tuberculosis Infection. Program Managers (manual)............... Targeted Testing and 18 1 30/60 Treatment for Latent Tuberculosis Infection. Data clerks (manual).................... Targeted Testing and 18 1 3 Treatment for Latent Tuberculosis Infection. ---------------------------------------------------------------------------------------------------------------- Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016-23072 Filed 9-23-16; 8:45 am] BILLING CODE 4163-18-P
![66030 Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices
of the meeting will be included in the Prevention and the Agency for Toxic Prevention and the Agency for Toxic
official record of the meeting. Substances and Disease Registry. Substances and Disease Registry.
The meeting will be webcast live via Elaine L. Baker, Elaine L. Baker,
the World Wide Web; for instructions Director, Management Analysis and Services Director, Management Analysis and Services
and more information on ACIP please Office, Centers for Disease Control and Office, Centers for Disease Control and
visit the ACIP Web site: http:// Prevention. Prevention.
www.cdc.gov/vaccines/acip/index.html. [FR Doc. 2016–23053 Filed 9–23–16; 8:45 am] [FR Doc. 2016–23055 Filed 9–23–16; 8:45 am]
Purpose: The committee is charged BILLING CODE 4160–18–P BILLING CODE 4163–18–P
with advising the Director, CDC, on the
appropriate use of immunizing agents.
In addition, under 42 U.S.C. §1396s, the DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND
HUMAN SERVICES HUMAN SERVICES
committee is mandated to establish and
periodically review and, as appropriate, Centers for Disease Control and
revise the list of vaccines for Centers for Disease Control and
Prevention
administration to vaccine-eligible Prevention
children through the Vaccines for [30Day–16–0457]
Children (VFC) program, along with Disease, Disability, and Injury
Prevention and Control Special Agency Forms Undergoing Paperwork
schedules regarding the appropriate
Emphasis Panel (SEP): Initial Review Reduction Act Review
periodicity, dosage, and
contraindications applicable to the In accordance with Section 10(a)(2) of The Centers for Disease Control and
vaccines. Further, under provisions of the Federal Advisory Committee Act Prevention (CDC) has submitted the
the Affordable Care Act, at section 2713 (Pub. L. 92–463), the Centers for Disease following information collection request
of the Public Health Service Act, Control and Prevention (CDC) to the Office of Management and Budget
immunization recommendations of the announces a meeting for the initial (OMB) for review and approval in
ACIP that have been adopted by the accordance with the Paperwork
review of applications in response to
Director of the Centers for Disease Reduction Act of 1995. The notice for
Funding Opportunity Announcement
Control and Prevention and appear on the proposed information collection is
(FOA) GH16–007, Operations Research
the CDC immunization schedules must published to obtain comments from the
(Implementation Science) for
be covered by applicable health plans. public and affected agencies.
Strengthening Global Health Protection
Written comments and suggestions
Matters for Discussion: The agenda Implementation. from the public and affected agencies
will include discussions on: Times and dates: 9:00 a.m.–2:00 p.m., concerning the proposed collection of
Meningococcal vaccines; human EDT, Panel A, October 18, 2016 information are encouraged. Your
papillomavirus vaccines; influenza; (Closed); 9:00 a.m.–2:00 p.m., EDT, comments should address any of the
hepatitis vaccines; pertussis vaccines; Panel B, October 19, 2016 (Closed). following: (a) Evaluate whether the
Respiratory Syncytial Virus (RSV); child proposed collection of information is
and adolescent immunization schedule; Place: Teleconference.
necessary for the proper performance of
adult immunization schedule; herpes Status: The meeting will be closed to the functions of the agency, including
zoster vaccine; yellow fever vaccine; the public in accordance with whether the information will have
pneumococcal vaccine and vaccine provisions set forth in Section practical utility; (b) Evaluate the
supply. A recommendation vote is 552b(c)(4) and (6), Title 5 U.S.C., and accuracy of the agencies estimate of the
scheduled for Hepatitis B vaccine, the Determination of the Director, burden of the proposed collection of
pertussis vaccine, human Management Analysis and Services information, including the validity of
papillomavirus vaccines, meningococcal Office, CDC, pursuant to Public Law 92– the methodology and assumptions used;
vaccines, child and adolescent 463. (c) Enhance the quality, utility, and
immunization schedule, and adult Matters for discussion: The meeting clarity of the information to be
immunization schedule. A Vaccines for will include the initial review, collected; (d) Minimize the burden of
Children (VFC) vote is scheduled for discussion, and evaluation of the collection of information on those
human papillomavirus vaccines, applications received in response to who are to respond, including through
Hepatitis B vaccine and meningococcal GH16–007 Operations Research the use of appropriate automated,
vaccines. Agenda items are subject to (Implementation Science) for electronic, mechanical, or other
change as priorities dictate. Strengthening Global Health Protection technological collection techniques or
Contact Person for More Information: Implementation. other forms of information technology,
Stephanie Thomas, National Center for e.g., permitting electronic submission of
Contact person for more information:
responses; and (e) Assess information
Immunization and Respiratory Diseases, Hylan Shoob, Scientific Review Officer,
collection costs.
CDC, 1600 Clifton Road NE., MS–A27, Center for Global Health (CGH) Science
To request additional information on
Atlanta, Georgia 30329, Telephone: Office, CGH, CDC, 1600 Clifton Road the proposed project or to obtain a copy
(404) 639–8836; Email: ACIP@ NE., Mailstop D–69, Atlanta, Georgia of the information collection plan and
CDC.GOV. 30329, Telephone: (404) 639–4796. instruments, call (404) 639–7570 or
mstockstill on DSK3G9T082PROD with NOTICES
The Director, Management Analysis The Director, Management Analysis send an email to omb@cdc.gov. Written
and Services Office, has been delegated and Services Office, has been delegated comments and/or suggestions regarding
the authority to sign Federal Register the authority to sign Federal Register the items contained in this notice
notices pertaining to announcements of notices pertaining to announcements of should be directed to the Attention:
meetings and other committee meetings and other committee CDC Desk Officer, Office of Management
management activities for both the management activities, for both the and Budget, Washington, DC 20503 or
Centers for Disease Control and Centers for Disease Control and by fax to (202) 395–5806. Written
VerDate Sep<11>2014 19:40 Sep 23, 2016 Jkt 238001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\26SEN1.SGM 26SEN1](https://thefederalregister.org/doc/81_FR_66216/page/1.svg)
![Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices 66031
comments should be received within 30 DTBE is the lead agency for populations vulnerable to tuberculosis,
days of this notice. tuberculosis elimination in the United and programmed electronic report entry,
States. To ensure the elimination of which transitioned to the National
Proposed Project
tuberculosis in the United States, CDC Tuberculosis Indicators Project (NTIP), a
Aggregate Reports for Tuberculosis monitors indicators for key program secure web-based system for program
Program Evaluation (OMB Control activities, such as finding tuberculosis evaluation data, in 2010. No other
Number 0920–0457)—Reinstatement infections in recent contacts of cases federal agency collects this type of
Without Change of a Previously and in other persons likely to be national tuberculosis data, and the
Approved Collection—National Center infected and providing therapy for Aggregate report of follow-up for
for HIV/AIDS, Viral Hepatitis, STD, and latent tuberculosis infection. contacts of tuberculosis, and Aggregate
TB Prevention (NCHHSTP), Centers for In 2000, CDC implemented two report of screening and preventive
Disease Control and Prevention (CDC). program evaluation reports for annual therapy for tuberculosis infection are
submission: Aggregate report of follow- the only data source about latent
Background and Brief Description
up for contacts of tuberculosis, and tuberculosis infection for monitoring
CDC, NCHHSTP, Division of Aggregate report of screening and national progress toward tuberculosis
Tuberculosis Elimination (DTBE) preventive therapy for tuberculosis elimination with these activities.
proposes a reinstatement without infection (OMB No. 0920–0457). The CDC provides ongoing assistance in
change of the Aggregate Reports for respondents for these reports were the the preparation and utilization of these
Tuberculosis Program Evaluation, 68 state and local tuberculosis control reports at the local and state levels of
previously approved under OMB programs receiving federal cooperative public health jurisdiction. CDC also
Control Number 0920–0457. This agreement funding through DTBE. This provides respondents with technical
request is for a three-year clearance. group will also respond to this support for NTIP access (Electronic—
There are no revisions to the report collection of information. 100%, Use of Electronic Signatures).
forms, data definitions, or reporting These Aggregate reports emphasize The annual burden to respondents is
instructions. treatment outcomes, high-priority target estimated to be 226 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per
Type of respondent Form name responses per
respondents response
respondent (in hours)
Data clerks and Program Managers Follow-up and Treatment of Contacts to Tuberculosis 100 1 30/60
(electronic). Cases Form.
Program Managers (manual) ............ Follow-up and Treatment of Contacts to Tuberculosis 18 1 30/60
Cases Form.
Data clerks (manual) ......................... Follow-up and Treatment of Contacts to Tuberculosis 18 1 3
Cases Form.
Data clerks and Program Managers Targeted Testing and Treatment for Latent Tuberculosis 100 1 30/60
(electronic). Infection.
Program Managers (manual) ............ Targeted Testing and Treatment for Latent Tuberculosis 18 1 30/60
Infection.
Data clerks (manual) ......................... Targeted Testing and Treatment for Latent Tuberculosis 18 1 3
Infection.
Leroy A. Richardson, DEPARTMENT OF HEALTH AND publish notice in the Federal Register
Chief, Information Collection Review Office, HUMAN SERVICES concerning each proposed collection of
Office of Scientific Integrity, Office of the information, including each proposed
Associate Director for Science, Office of the Centers for Medicare & Medicaid extension or reinstatement of an existing
Director, Centers for Disease Control and Services collection of information, and to allow
Prevention. a second opportunity for public
[Document Identifiers: CMS–R–70, CMS–R–
[FR Doc. 2016–23072 Filed 9–23–16; 8:45 am] 72, CMS–R–247, CMS–10062, CMS–10268, comment on the notice. Interested
BILLING CODE 4163–18–P CMS–10615 and CMS–10623] persons are invited to send comments
regarding the burden estimate or any
Agency Information Collection
other aspect of this collection of
Activities: Submission for OMB
information, including any of the
Review; Comment Request
following subjects: (1) The necessity and
AGENCY: Centers for Medicare & utility of the proposed information
Medicaid Services. collection for the proper performance of
ACTION: Notice. the agency’s functions; (2) the accuracy
mstockstill on DSK3G9T082PROD with NOTICES
of the estimated burden; (3) ways to
SUMMARY: The Centers for Medicare &
enhance the quality, utility, and clarity
Medicaid Services (CMS) is announcing
of the information to be collected; and
an opportunity for the public to
(4) the use of automated collection
comment on CMS’ intention to collect
information from the public. Under the techniques or other forms of information
Paperwork Reduction Act of 1995 technology to minimize the information
(PRA), federal agencies are required to collection burden.
VerDate Sep<11>2014 19:40 Sep 23, 2016 Jkt 238001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\26SEN1.SGM 26SEN1](https://thefederalregister.org/doc/81_FR_66216/page/2.svg)
Document Created: 2018-02-09 13:22:45
Document Modified: 2018-02-09 13:22:45
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 81 FR 66030 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR